Healthcare Sector Stocks
The Healthcare sector has a total of 1058 stocks, with a combined market cap of $9.12 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 45.83.
Market Cap
9.12T
Revenue
4.59T
Profits
199.02B
PE Ratio
45.83
Profit Margin
4.34%
Dividend Yield
0.39%
1059 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.08T | -1.60% | 2,608,557 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 634.06B | -1.44% | 6,769,425 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 446.54B | -0.75% | 7,578,707 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 386.51B | -0.60% | 3,859,209 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 311.17B | -2.23% | 7,910,217 | 65.77B |
| 6 | AZN | AstraZeneca PLC | 295.16B | -1.99% | 1,967,847 | 60.44B |
| 7 | NVS | Novartis AG | 284.61B | -1.18% | 1,420,131 | 56.58B |
| 8 | NVO | Novo Nordisk A/S | 218.12B | -1.51% | 9,137,800 | 50.57B |
| 9 | AMGN | Amgen Inc. | 198.61B | -0.03% | 1,758,926 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 189.58B | -1.26% | 2,021,579 | 45.20B |
| 11 | GILD | Gilead Sciences, Inc. | 168.63B | -0.40% | 8,454,143 | 29.74B |
| 12 | ABT | Abbott Laboratories | 165.79B | -0.69% | 10,102,296 | 45.13B |
| 13 | ISRG | Intuitive Surgical, Inc. | 147.01B | -2.86% | 1,614,811 | 10.58B |
| 14 | PFE | Pfizer Inc. | 137.07B | -0.08% | 38,181,252 | 63.32B |
| 15 | DHR | Danaher Corporation | 135.02B | -1.76% | 2,502,661 | 24.78B |
| 16 | CVS | CVS Health Corporation | 133.30B | 0.13% | 4,766,556 | 405.62B |
| 17 | VRTX | Vertex Pharmaceuticals Incorporated | 126.50B | -4.56% | 2,287,223 | 12.22B |
| 18 | SYK | Stryker Corporation | 125.30B | -0.88% | 2,319,847 | 25.27B |
| 19 | BMY | Bristol-Myers Squibb Company | 117.50B | -0.74% | 8,004,476 | 48.48B |
| 20 | GSK | GSK plc | 105.41B | -1.50% | 3,083,707 | 43.29B |
| 21 | MDT | Medtronic plc | 104.98B | -2.17% | 5,746,777 | 36.36B |
| 22 | SNY | Sanofi | 103.14B | -0.47% | 1,899,903 | 54.60B |
| 23 | MCK | McKesson Corporation | 95.85B | 1.40% | 1,125,390 | 403.43B |
| 24 | HCA | HCA Healthcare, Inc. | 91.09B | -2.95% | 1,650,380 | 76.39B |
| 25 | ELV | Elevance Health, Inc. | 90.36B | -0.66% | 1,280,188 | 200.42B |
| 26 | CI | The Cigna Group | 76.64B | 1.09% | 1,196,530 | 277.89B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 67.44B | -1.97% | 746,835 | 14.92B |
| 28 | BSX | Boston Scientific Corporation | 66.60B | -1.08% | 13,549,494 | 20.61B |
| 29 | COR | Cencora, Inc. | 60.23B | 1.67% | 2,259,745 | 328.68B |
| 30 | ARGX | argenx SE | 56.71B | -0.50% | 245,355 | 4.74B |
| 31 | CAH | Cardinal Health, Inc. | 55.54B | -1.07% | 2,693,642 | 250.74B |
| 32 | EW | Edwards Lifesciences Corporation | 53.92B | -1.24% | 3,673,431 | 6.30B |
| 33 | MDLN | Medline Inc. | 52.94B | -6.30% | 8,919,112 | 29.14B |
| 34 | TAK | Takeda Pharmaceutical Company Limited | 52.43B | -1.24% | 2,241,548 | 28.34B |
| 35 | HUM | Humana Inc. | 47.58B | 0.42% | 1,182,076 | 137.20B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 43.83B | -2.56% | 578,565 | 4.45B |
| 37 | ALNY | Alnylam Pharmaceuticals, Inc. | 43.19B | 0.59% | 897,702 | 4.29B |
| 38 | HLN | Haleon plc | 42.83B | -0.91% | 6,533,070 | 14.85B |
| 39 | BDX | Becton, Dickinson and Company | 41.49B | -3.67% | 2,287,663 | 22.23B |
| 40 | RVMD | Revolution Medicines, Inc. | 40.34B | -0.36% | 1,983,108 | - |
| 41 | NTRA | Natera, Inc. | 39.30B | -2.45% | 1,398,594 | 2.50B |
| 42 | TEVA | Teva Pharmaceutical Industries Limited | 38.71B | -4.07% | 6,623,728 | 17.35B |
| 43 | A | Agilent Technologies, Inc. | 36.45B | -1.58% | 2,141,150 | 7.23B |
| 44 | WAT | Waters Corporation | 36.15B | -1.81% | 838,101 | 3.77B |
| 45 | IQV | IQVIA Holdings Inc. | 34.01B | -2.13% | 1,036,073 | 16.63B |
| 46 | RPRX | Royalty Pharma plc | 33.61B | 0.99% | 3,281,287 | 2.44B |
| 47 | ONC | BeOne Medicines AG | 33.56B | -2.29% | 310,383 | 5.74B |
| 48 | CNC | Centene Corporation | 33.13B | 1.47% | 4,098,276 | 178.33B |
| 49 | ALC | Alcon Inc. | 32.52B | -0.46% | 2,806,197 | 10.63B |
| 50 | ZTS | Zoetis Inc. | 31.48B | -1.56% | 4,838,121 | 9.53B |
| 51 | VEEV | Veeva Systems Inc. | 30.57B | -2.15% | 1,678,241 | 3.32B |
| 52 | RMD | ResMed Inc. | 29.69B | -6.33% | 1,761,756 | 5.54B |
| 53 | BIIB | Biogen Inc. | 29.58B | -2.60% | 1,947,888 | 9.94B |
| 54 | GEHC | GE HealthCare Technologies Inc. | 29.42B | -0.32% | 4,039,185 | 20.98B |
| 55 | MRNA | Moderna, Inc. | 29.28B | -7.48% | 6,581,663 | 2.23B |
| 56 | DXCM | DexCom, Inc. | 28.58B | 0.67% | 5,338,783 | 4.82B |
| 57 | ILMN | Illumina, Inc. | 28.42B | -2.06% | 2,650,617 | 4.39B |
| 58 | PHG | Koninklijke Philips N.V. | 26.15B | -2.30% | 753,976 | 20.34B |
| 59 | ROIV | Roivant Sciences Ltd. | 25.96B | -0.61% | 4,267,939 | 8.26M |
| 60 | INSM | Insmed Incorporated | 25.26B | 3.27% | 2,835,057 | 819.56M |
| 61 | MTD | Mettler-Toledo International Inc. | 25.24B | -3.60% | 156,578 | 4.09B |
| 62 | WST | West Pharmaceutical Services, Inc. | 24.99B | -0.67% | 924,011 | 3.22B |
| 63 | BNTX | BioNTech SE | 23.65B | -0.81% | 686,517 | 3.23B |
| 64 | UTHR | United Therapeutics Corporation | 23.53B | -1.66% | 299,416 | 3.17B |
| 65 | INCY | Incyte Corporation | 23.43B | -0.67% | 1,878,406 | 5.36B |
| 66 | DGX | Quest Diagnostics Incorporated | 23.05B | -1.56% | 773,651 | 11.28B |
| 67 | LH | Labcorp Holdings Inc. | 22.77B | -2.16% | 525,636 | 14.14B |
| 68 | GH | Guardant Health, Inc. | 20.71B | -4.14% | 3,335,446 | 1.08B |
| 69 | STE | STERIS plc | 20.42B | -2.74% | 604,699 | 5.94B |
| 70 | VTRS | Viatris Inc. | 19.40B | -1.77% | 8,683,562 | 14.56B |
| 71 | NBIX | Neurocrine Biosciences, Inc. | 17.92B | 0.42% | 1,155,803 | 3.10B |
| 72 | THC | Tenet Healthcare Corporation | 17.77B | -1.23% | 773,993 | 21.46B |
| 73 | GMAB | Genmab A/S | 17.71B | 1.23% | 2,737,591 | 3.90B |
| 74 | ASND | Ascendis Pharma A/S | 17.22B | 3.82% | 739,670 | 998.25M |
| 75 | ZBH | Zimmer Biomet Holdings, Inc. | 16.94B | -2.07% | 1,615,545 | 8.41B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 15.59B | 0.21% | 856,417 | 4.44B |
| 77 | BBIO | BridgeBio Pharma, Inc. | 15.36B | 0.54% | 2,060,863 | 579.96M |
| 78 | MEDP | Medpace Holdings, Inc. | 15.19B | -2.62% | 347,454 | 2.68B |
| 79 | DVA | DaVita Inc. | 14.81B | -1.53% | 850,497 | 13.84B |
| 80 | BTSG | BrightSpring Health Services, Inc. | 14.69B | 0.47% | 3,030,175 | 13.65B |
| 81 | EXEL | Exelixis, Inc. | 14.10B | -1.70% | 1,783,224 | 2.38B |
| 82 | IONS | Ionis Pharmaceuticals, Inc. | 13.96B | -2.17% | 2,280,834 | 1.06B |
| 83 | COO | The Cooper Companies, Inc. | 13.58B | -3.17% | 3,099,532 | 4.23B |
| 84 | MDGL | Madrigal Pharmaceuticals, Inc. | 13.04B | 3.67% | 468,253 | 1.13B |
| 85 | SOLV | Solventum Corporation | 13.02B | -1.44% | 964,198 | 8.26B |
| 86 | FMS | Fresenius Medical Care AG | 12.86B | -1.07% | 449,182 | 22.32B |
| 87 | SNN | Smith & Nephew plc | 12.69B | -1.74% | 983,273 | 6.16B |
| 88 | ICLR | ICON Public Limited Company | 12.68B | -1.93% | 653,782 | 8.27B |
| 89 | AXSM | Axsome Therapeutics, Inc. | 12.64B | -1.68% | 769,422 | 708.24M |
| 90 | ALGN | Align Technology, Inc. | 12.51B | -5.69% | 1,018,657 | 4.10B |
| 91 | PEN | Penumbra, Inc. | 12.48B | -0.32% | 258,126 | 1.45B |
| 92 | ELAN | Elanco Animal Health Incorporated | 12.33B | 0.20% | 4,616,997 | 4.89B |
| 93 | RVTY | Revvity, Inc. | 12.20B | -2.41% | 939,448 | 2.90B |
| 94 | SMMT | Summit Therapeutics Inc. | 12.18B | -1.20% | 2,775,792 | - |
| 95 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.08B | -1.41% | 1,660,445 | 622.01M |
| 96 | MOH | Molina Healthcare, Inc. | 12.03B | -0.84% | 1,055,875 | 43.10B |
| 97 | ABVX | ABIVAX Société Anonyme | 12.00B | -2.55% | 1,261,195 | 5.67M |
| 98 | BMRN | BioMarin Pharmaceutical Inc. | 11.55B | -0.99% | 1,545,555 | 3.24B |
| 99 | CYTK | Cytokinetics, Incorporated | 11.52B | -0.79% | 2,377,531 | 105.82M |
| 100 | BAX | Baxter International Inc. | 11.35B | -3.85% | 6,788,762 | 11.32B |
| 101 | KRYS | Krystal Biotech, Inc. | 11.07B | 1.84% | 234,235 | 417.30M |
| 102 | TECH | Bio-Techne Corporation | 11.06B | 0.50% | 5,691,315 | 1.21B |
| 103 | RDY | Dr. Reddy's Laboratories Limited | 11.04B | -3.49% | 4,492,691 | 3.58B |
| 104 | EHC | Encompass Health Corporation | 10.94B | -0.42% | 1,154,828 | 6.07B |
| 105 | PODD | Insulet Corporation | 10.91B | -2.53% | 977,283 | 2.90B |
| 106 | CRL | Charles River Laboratories International, Inc. | 10.79B | -2.06% | 740,867 | 4.03B |
| 107 | GMED | Globus Medical, Inc. | 10.34B | -3.34% | 2,257,663 | 3.10B |
| 108 | TEM | Tempus AI, Inc. | 10.28B | -4.69% | 4,750,298 | 1.36B |
| 109 | APGE | Apogee Therapeutics, Inc. | 9.99B | -0.22% | 2,543,882 | - |
| 110 | CORT | Corcept Therapeutics Incorporated | 9.98B | -1.17% | 1,037,212 | 769.10M |
| 111 | ENSG | The Ensign Group, Inc. | 9.85B | -0.55% | 469,665 | 5.27B |
| 112 | NUVL | Nuvalent, Inc. | 9.82B | 0.02% | 1,160,977 | - |
| 113 | HALO | Halozyme Therapeutics, Inc. | 9.53B | -1.47% | 2,487,012 | 1.51B |
| 114 | HSIC | Henry Schein, Inc. | 9.48B | -4.17% | 1,514,277 | 13.38B |
| 115 | UHS | Universal Health Services, Inc. | 9.47B | -3.00% | 1,207,649 | 17.76B |
| 116 | KYMR | Kymera Therapeutics, Inc. | 9.39B | -4.26% | 788,046 | 51.48M |
| 117 | PRAX | Praxis Precision Medicines, Inc. | 9.28B | 2.79% | 559,330 | 7.46M |
| 118 | OSCR | Oscar Health, Inc. | 9.28B | -1.00% | 4,228,644 | 13.30B |
| 119 | IBRX | ImmunityBio, Inc. | 9.22B | 0.46% | 9,756,607 | 140.98M |
| 120 | ALKS | Alkermes plc | 9.05B | -1.68% | 1,706,012 | 1.56B |
| 121 | PTGX | Protagonist Therapeutics, Inc. | 9.01B | -0.55% | 931,359 | 74.06M |
| 122 | GKOS | Glaukos Corporation | 8.98B | 1.53% | 1,058,781 | 551.35M |
| 123 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.80B | -0.05% | 17,889,941 | 18.07M |
| 124 | BRKR | Bruker Corporation | 8.71B | -1.79% | 1,652,127 | 3.46B |
| 125 | PCVX | Vaxcyte, Inc. | 8.48B | -3.23% | 1,632,340 | - |
| 126 | HIMS | Hims & Hers Health, Inc. | 8.35B | -0.28% | 12,576,346 | 2.37B |
| 127 | SYRE | Spyre Therapeutics, Inc. | 8.28B | 1.24% | 1,240,474 | - |
| 128 | IMVT | Immunovant, Inc. | 8.28B | 0.55% | 1,174,141 | - |
| 129 | TGTX | TG Therapeutics, Inc. | 8.11B | -1.43% | 1,854,934 | 700.35M |
| 130 | ATR | AptarGroup, Inc. | 7.93B | -2.73% | 537,700 | 3.87B |
| 131 | HQY | HealthEquity, Inc. | 7.92B | -2.32% | 711,750 | 1.34B |
| 132 | QGEN | Qiagen N.V. | 7.86B | -1.86% | 2,508,872 | 2.10B |
| 133 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.84B | -0.03% | 763,005 | 217.17M |
| 134 | MIRM | Mirum Pharmaceuticals, Inc. | 7.84B | 0.20% | 885,142 | 569.61M |
| 135 | RGEN | Repligen Corporation | 7.75B | -1.73% | 689,024 | 763.34M |
| 136 | BIO | Bio-Rad Laboratories, Inc. | 7.60B | -2.95% | 253,113 | 2.59B |
| 137 | PTCT | PTC Therapeutics, Inc. | 7.35B | -0.71% | 1,328,350 | 827.11M |
| 138 | LQDA | Liquidia Corporation | 7.07B | -2.17% | 1,738,414 | 288.07M |
| 139 | PACS | PACS Group, Inc. | 6.97B | 0.92% | 763,525 | 5.43B |
| 140 | LNTH | Lantheus Holdings, Inc. | 6.95B | 3.23% | 701,667 | 1.55B |
| 141 | HNGE | Hinge Health, Inc. | 6.85B | -0.90% | 1,775,326 | 646.34M |
| 142 | COGT | Cogent Biosciences, Inc. | 6.83B | -0.10% | 3,643,212 | - |
| 143 | XENE | Xenon Pharmaceuticals Inc. | 6.76B | 10.38% | 4,763,965 | 7.50M |
| 144 | SRRK | Scholar Rock Holding Corporation | 6.71B | -0.94% | 757,650 | - |
| 145 | AVTR | Avantor, Inc. | 6.66B | -4.31% | 6,986,828 | 6.55B |
| 146 | CHE | Chemed Corporation | 6.34B | -1.16% | 158,854 | 2.54B |
| 147 | LGND | Ligand Pharmaceuticals Incorporated | 6.24B | -1.42% | 404,996 | 274.48M |
| 148 | GRFS | Grifols, S.A. | 6.19B | 1.39% | 423,655 | 8.58B |
| 149 | CGON | CG Oncology, Inc. | 6.16B | 0.87% | 1,371,309 | 5.07M |
| 150 | DFTX | Definium Therapeutics, Inc. | 6.02B | 1.89% | 2,616,824 | - |
| 151 | BLTE | Belite Bio, Inc | 5.99B | -3.42% | 311,872 | - |
| 152 | BLCO | Bausch + Lomb Corporation | 5.94B | -2.57% | 363,224 | 5.21B |
| 153 | ERAS | Erasca, Inc. | 5.87B | 2.78% | 5,956,973 | - |
| 154 | TFX | Teleflex Incorporated | 5.77B | -2.39% | 267,284 | 2.13B |
| 155 | CRSP | CRISPR Therapeutics AG | 5.71B | -2.58% | 1,226,595 | 4.10M |
| 156 | TWST | Twist Bioscience Corporation | 5.57B | -1.81% | 1,722,845 | 409.48M |
| 157 | BLLN | BillionToOne, Inc. | 5.55B | 2.17% | 630,340 | 354.54M |
| 158 | TVTX | Travere Therapeutics, Inc. | 5.43B | 0.88% | 1,549,364 | 536.20M |
| 159 | AMRX | Amneal Pharmaceuticals, Inc. | 5.41B | -0.53% | 1,752,329 | 3.05B |
| 160 | LEGN | Legend Biotech Corporation | 5.39B | 0.69% | 1,167,558 | 1.14B |
| 161 | DNTH | Dianthus Therapeutics, Inc. | 5.36B | 2.41% | 754,362 | 1.34M |
| 162 | CELC | Celcuity Inc. | 5.31B | -5.89% | 1,516,709 | - |
| 163 | STVN | Stevanato Group S.p.A. | 5.27B | -1.38% | 298,532 | 1.39B |
| 164 | RDNT | RadNet, Inc. | 5.16B | -3.30% | 673,633 | 2.14B |
| 165 | ORKA | Oruka Therapeutics, Inc. | 5.09B | -0.12% | 1,042,685 | - |
| 166 | INDV | Indivior Pharmaceuticals, Inc. | 4.99B | 0.15% | 1,290,572 | 1.29B |
| 167 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.98B | -3.76% | 1,059,909 | 754.05M |
| 168 | SHC | Sotera Health Company | 4.98B | -3.05% | 3,381,615 | 1.19B |
| 169 | EWTX | Edgewise Therapeutics, Inc. | 4.98B | 7.35% | 2,469,179 | - |
| 170 | MANE | Veradermics, Incorporated | 4.94B | 1.24% | 373,347 | - |
| 171 | CAI | Caris Life Sciences, Inc. | 4.90B | -0.86% | 2,825,875 | 907.29M |
| 172 | TXG | 10x Genomics, Inc. | 4.76B | -0.95% | 3,100,234 | 638.78M |
| 173 | VKTX | Viking Therapeutics, Inc. | 4.64B | -5.15% | 3,341,214 | - |
| 174 | LIVN | LivaNova PLC | 4.53B | -1.28% | 724,839 | 1.43B |
| 175 | VCYT | Veracyte, Inc. | 4.48B | -0.07% | 1,358,753 | 541.74M |
| 176 | ACAD | ACADIA Pharmaceuticals Inc. | 4.45B | -0.76% | 1,551,854 | 1.10B |
| 177 | TNGX | Tango Therapeutics, Inc. | 4.43B | 1.73% | 3,974,869 | 56.99M |
| 178 | WAY | Waystar Holding Corp. | 4.36B | -4.58% | 1,954,762 | 1.16B |
| 179 | RLAY | Relay Therapeutics, Inc. | 4.28B | -0.56% | 4,312,269 | 10.68M |
| 180 | MMSI | Merit Medical Systems, Inc. | 4.24B | -1.50% | 647,382 | 1.54B |
| 181 | DNLI | Denali Therapeutics Inc. | 4.24B | 1.44% | 1,300,642 | - |
| 182 | MMED | MiniMed Group, Inc. | 4.22B | -2.28% | 1,055,690 | 3.10B |
| 183 | NAMS | NewAmsterdam Pharma Company N.V. | 4.19B | -3.14% | 716,991 | 22.57M |
| 184 | NVST | Envista Holdings Corporation | 4.19B | -5.12% | 3,301,533 | 2.81B |
| 185 | ALHC | Alignment Healthcare, Inc. | 4.14B | -16.72% | 15,361,382 | 4.26B |
| 186 | IRTC | iRhythm Holdings, Inc. | 4.12B | 0.20% | 839,862 | 787.85M |
| 187 | LFST | LifeStance Health Group, Inc. | 4.07B | -3.76% | 4,490,019 | 1.49B |
| 188 | CON | Concentra Group Holdings Parent, Inc. | 4.03B | -0.54% | 903,674 | 2.23B |
| 189 | TLX | Telix Pharmaceuticals Limited | 3.97B | -1.62% | 206,914 | 803.79M |
| 190 | DOCS | Doximity, Inc. | 3.97B | -4.62% | 2,829,124 | 644.86M |
| 191 | DYN | Dyne Therapeutics, Inc. | 3.94B | - | 2,528,261 | - |
| 192 | PBLS | Parabilis Medicines, Inc. | 3.93B | 1.58% | 399,172 | - |
| 193 | GPCR | Structure Therapeutics Inc. | 3.90B | -3.07% | 858,098 | - |
| 194 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.85B | -0.06% | 4,210,591 | 596.96M |
| 195 | RCUS | Arcus Biosciences, Inc. | 3.81B | 0.03% | 1,135,939 | 236.00M |
| 196 | ICUI | ICU Medical, Inc. | 3.80B | -2.24% | 211,342 | 2.16B |
| 197 | ALMS | Alumis Inc. | 3.79B | 1.61% | 2,714,465 | 8.40M |
| 198 | BEAM | Beam Therapeutics Inc. | 3.67B | -2.74% | 3,931,070 | 164.01M |
| 199 | IDYA | IDEAYA Biosciences, Inc. | 3.61B | -6.29% | 1,437,646 | 225.27M |
| 200 | BKD | Brookdale Senior Living Inc. | 3.58B | -2.66% | 5,832,565 | 3.00B |
| 201 | ARQT | Arcutis Biotherapeutics, Inc. | 3.56B | 3.00% | 1,804,102 | 415.62M |
| 202 | ELVN | Enliven Therapeutics, Inc. | 3.55B | -0.24% | 1,117,930 | - |
| 203 | OGN | Organon & Co. | 3.54B | -0.30% | 4,065,711 | 6.16B |
| 204 | PRVA | Privia Health Group, Inc. | 3.43B | -0.07% | 1,481,849 | 2.25B |
| 205 | RARE | Ultragenyx Pharmaceutical Inc. | 3.40B | -3.35% | 2,775,855 | 670.00M |
| 206 | WRBY | Warby Parker Inc. | 3.40B | -1.32% | 2,428,252 | 890.57M |
| 207 | OPCH | Option Care Health, Inc. | 3.37B | -0.46% | 2,369,782 | 5.67B |
| 208 | HAE | Haemonetics Corporation | 3.35B | -1.42% | 618,766 | 1.33B |
| 209 | NHC | National HealthCare Corporation | 3.31B | -2.13% | 113,312 | 1.53B |
| 210 | ADPT | Adaptive Biotechnologies Corporation | 3.23B | -3.17% | 2,513,999 | 295.41M |
| 211 | RGC | Regencell Bioscience Holdings Limited | 3.22B | 9.08% | 1,460,228 | - |
| 212 | ITGR | Integer Holdings Corporation | 3.09B | -0.82% | 649,949 | 1.86B |
| 213 | IRON | Disc Medicine, Inc. | 3.06B | 0.38% | 538,751 | - |
| 214 | CLDX | Celldex Therapeutics, Inc. | 3.06B | -2.43% | 1,618,303 | 865.00K |
| 215 | VERA | Vera Therapeutics, Inc. | 3.05B | -1.23% | 3,862,278 | - |
| 216 | GRAL | GRAIL, Inc. | 3.01B | 1.96% | 835,183 | 156.12M |
| 217 | QURE | uniQure N.V. | 2.99B | 5.02% | 1,904,917 | 18.09M |
| 218 | MBX | MBX Biosciences, Inc. | 2.94B | -0.42% | 1,469,551 | - |
| 219 | SUPN | Supernus Pharmaceuticals, Inc. | 2.93B | 5.21% | 1,430,877 | 776.83M |
| 220 | TARS | Tarsus Pharmaceuticals, Inc. | 2.91B | -4.00% | 1,330,644 | 535.08M |
| 221 | ACHC | Acadia Healthcare Company, Inc. | 2.83B | -3.70% | 2,009,515 | 3.37B |
| 222 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.82B | 1.09% | 7,429,410 | 885.72M |
| 223 | KLRA | Kailera Therapeutics, Inc. | 2.82B | -2.16% | 812,824 | - |
| 224 | IMNM | Immunome, Inc. | 2.72B | -1.56% | 2,191,995 | 4.02M |
| 225 | SLS | SELLAS Life Sciences Group, Inc. | 2.71B | 1.93% | 15,193,988 | - |
| 226 | MLYS | Mineralys Therapeutics, Inc. | 2.68B | -0.20% | 995,379 | - |
| 227 | TRVI | Trevi Therapeutics, Inc. | 2.64B | -4.67% | 2,555,257 | - |
| 228 | ESTA | Establishment Labs Holdings Inc. | 2.59B | -3.35% | 661,438 | 229.58M |
| 229 | GRDN | Guardian Pharmacy Services, Inc. | 2.56B | 1.05% | 562,209 | 1.46B |
| 230 | AGIO | Agios Pharmaceuticals, Inc. | 2.54B | -2.84% | 1,618,460 | 66.05M |
| 231 | KOD | Kodiak Sciences Inc. | 2.54B | 6.08% | 943,459 | - |
| 232 | NRIX | Nurix Therapeutics, Inc. | 2.51B | -0.37% | 1,404,748 | 71.78M |
| 233 | PHVS | Pharvaris N.V. | 2.51B | 3.86% | 950,385 | - |
| 234 | BHVN | Biohaven Ltd. | 2.51B | 7.01% | 3,815,137 | - |
| 235 | CLOV | Clover Health Investments, Corp. | 2.45B | -6.80% | 7,391,325 | 2.21B |
| 236 | TMDX | TransMedics Group, Inc. | 2.43B | -0.95% | 863,156 | 635.89M |
| 237 | NKTR | Nektar Therapeutics | 2.43B | -4.01% | 850,469 | 55.63M |
| 238 | PGNY | Progyny, Inc. | 2.41B | -0.06% | 1,847,630 | 1.29B |
| 239 | VCEL | Vericel Corporation | 2.40B | 0.15% | 704,815 | 292.09M |
| 240 | XRAY | DENTSPLY SIRONA Inc. | 2.36B | -3.36% | 4,627,574 | 3.68B |
| 241 | NTLA | Intellia Therapeutics, Inc. | 2.35B | -3.38% | 3,547,444 | 66.09M |
| 242 | LMAT | LeMaitre Vascular, Inc. | 2.33B | -3.67% | 414,463 | 256.28M |
| 243 | ASTH | Astrana Health, Inc. | 2.29B | -1.62% | 470,873 | 3.53B |
| 244 | PBH | Prestige Consumer Healthcare Inc. | 2.29B | -4.22% | 479,582 | 1.09B |
| 245 | AXGN | Axogen, Inc. | 2.27B | -4.08% | 1,052,341 | 238.11M |
| 246 | HTFL | HeartFlow, Inc. | 2.26B | -4.18% | 1,280,876 | 191.42M |
| 247 | OCUL | Ocular Therapeutix, Inc. | 2.25B | -0.58% | 3,201,097 | 52.04M |
| 248 | ZLAB | Zai Lab Limited | 2.22B | 2.07% | 1,353,740 | 453.28M |
| 249 | HRMY | Harmony Biosciences Holdings, Inc. | 2.20B | -0.47% | 833,725 | 899.11M |
| 250 | VRDN | Viridian Therapeutics, Inc. | 2.19B | -2.98% | 1,720,540 | 70.92M |
| 251 | SNDX | Syndax Pharmaceuticals, Inc. | 2.18B | 5.68% | 4,017,733 | 217.17M |
| 252 | ABCL | AbCellera Biologics Inc. | 2.17B | -7.67% | 9,395,282 | 79.21M |
| 253 | MD | Pediatrix Medical Group, Inc. | 2.15B | -0.22% | 865,726 | 1.93B |
| 254 | SGRY | Surgery Partners, Inc. | 2.14B | -3.90% | 1,315,396 | 3.34B |
| 255 | SRPT | Sarepta Therapeutics, Inc. | 2.13B | 2.12% | 3,311,712 | 2.18B |
| 256 | ADMA | ADMA Biologics, Inc. | 2.12B | -0.54% | 2,284,859 | 509.86M |
| 257 | AVAH | Aveanna Healthcare Holdings Inc. | 2.09B | -0.10% | 3,015,160 | 2.52B |
| 258 | AUPH | Aurinia Pharmaceuticals Inc. | 2.09B | 0.06% | 1,992,153 | 298.30M |
| 259 | PVLA | Palvella Therapeutics, Inc. | 2.08B | -0.35% | 121,111 | - |
| 260 | TSHA | Taysha Gene Therapies, Inc. | 2.08B | -0.15% | 2,648,552 | 7.47M |
| 261 | OMCL | Omnicell, Inc. | 2.05B | 1.71% | 815,939 | 1.23B |
| 262 | NUVB | Nuvation Bio Inc. | 2.04B | 3.53% | 10,530,046 | 143.05M |
| 263 | GENB | Generate Biomedicines, Inc. | 2.03B | -2.16% | 804,321 | 30.30M |
| 264 | STOK | Stoke Therapeutics, Inc. | 2.03B | -1.12% | 1,010,903 | 32.08M |
| 265 | GLUE | Monte Rosa Therapeutics, Inc. | 2.03B | -1.39% | 1,780,473 | 42.95M |
| 266 | NEOG | Neogen Corporation | 2.02B | -1.38% | 1,241,379 | 870.56M |
| 267 | LKFT | Lakefront Biotherapeutics NV | 2.01B | 0.75% | 98,746 | 1.20B |
| 268 | NVCR | NovoCure Limited | 2.01B | -1.98% | 3,335,528 | 674.41M |
| 269 | RAPP | Rapport Therapeutics, Inc. | 2.01B | 5.72% | 981,830 | 20.00M |
| 270 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.99B | -1.60% | 909,250 | -665.00K |
| 271 | SION | Sionna Therapeutics, Inc. | 1.99B | -2.07% | 573,837 | - |
| 272 | KARD | Kardigan, Inc. | 1.99B | -6.76% | 653,143 | - |
| 273 | PGEN | Precigen, Inc. | 1.98B | 0.91% | 3,738,939 | 31.60M |
| 274 | RXRX | Recursion Pharmaceuticals, Inc. | 1.97B | -3.12% | 22,705,629 | 66.41M |
| 275 | HCM | HUTCHMED (China) Limited | 1.96B | 0.36% | 41,650 | 548.51M |
| 276 | WGS | GeneDx Holdings Corp. | 1.95B | 0.31% | 552,036 | 442.68M |
| 277 | UFPT | UFP Technologies, Inc. | 1.95B | -4.77% | 215,090 | 608.85M |
| 278 | PLSE | Pulse Biosciences, Inc. | 1.95B | 0.29% | 221,685 | 751.00K |
| 279 | ADUS | Addus HomeCare Corporation | 1.94B | 0.33% | 287,376 | 1.45B |
| 280 | TYRA | Tyra Biosciences, Inc. | 1.94B | 1.97% | 614,559 | - |
| 281 | ANAB | AnaptysBio, Inc. | 1.93B | -2.94% | 1,164,821 | 232.39M |
| 282 | NBTX | Nanobiotix S.A. | 1.93B | - | 62,068 | 38.27M |
| 283 | BFLY | Butterfly Network, Inc. | 1.92B | -3.17% | 5,792,941 | 102.92M |
| 284 | IOVA | Iovance Biotherapeutics, Inc. | 1.91B | -1.61% | 10,335,109 | 285.61M |
| 285 | ZYME | Zymeworks Inc. | 1.91B | -0.26% | 901,580 | 81.26M |
| 286 | BCAX | Bicara Therapeutics Inc. | 1.90B | -4.64% | 867,383 | - |
| 287 | ATAI | AtaiBeckley Inc. | 1.90B | -0.39% | 10,126,434 | 3.49M |
| 288 | CMPS | COMPASS Pathways plc | 1.88B | 7.51% | 7,532,720 | - |
| 289 | MESO | Mesoblast Limited | 1.88B | 3.57% | 501,167 | 65.38M |
| 290 | ABSI | Absci Corporation | 1.88B | -2.03% | 6,599,911 | 1.84M |
| 291 | SNDA | Sonida Senior Living, Inc. | 1.87B | -2.20% | 373,730 | 367.34M |
| 292 | AGL | agilon health, inc. | 1.87B | 4.02% | 399,510 | 5.82B |
| 293 | NEO | NeoGenomics, Inc. | 1.85B | -1.79% | 2,815,752 | 745.97M |
| 294 | URGN | UroGen Pharma Ltd. | 1.85B | 0.74% | 715,902 | 140.49M |
| 295 | GHRS | GH Research PLC | 1.84B | -0.15% | 186,267 | - |
| 296 | BHC | Bausch Health Companies Inc. | 1.83B | - | 1,209,561 | 10.53B |
| 297 | ZBIO | Zenas BioPharma, Inc. | 1.82B | 3.92% | 795,932 | 10.00M |
| 298 | ANIP | ANI Pharmaceuticals, Inc. | 1.80B | -1.42% | 228,563 | 923.71M |
| 299 | MAZE | Maze Therapeutics, Inc. | 1.77B | -2.59% | 1,097,406 | 20.00M |
| 300 | VIR | Vir Biotechnology, Inc. | 1.76B | 1.76% | 1,952,005 | 65.50M |
| 301 | ALMR | Alamar Biosciences, Inc. | 1.75B | 0.28% | 165,637 | 87.16M |
| 302 | MPLT | MapLight Therapeutics, Inc. | 1.75B | 3.97% | 374,099 | - |
| 303 | IMCR | Immunocore Holdings plc | 1.72B | 1.14% | 469,774 | 412.81M |
| 304 | TRLV | Trulieve Cannabis Corp. | 1.71B | -0.45% | 863,812 | 1.17B |
| 305 | ATRC | AtriCure, Inc. | 1.70B | 2.62% | 801,386 | 552.16M |
| 306 | DMRA | Damora Therapeutics, Inc. | 1.69B | -8.23% | 678,858 | - |
| 307 | HROW | Harrow, Inc. | 1.68B | -2.34% | 534,030 | 268.68M |
| 308 | INVA | Innoviva, Inc. | 1.66B | 0.81% | 978,643 | 420.69M |
| 309 | SEPN | Septerna, Inc. | 1.64B | 1.59% | 945,174 | 72.26M |
| 310 | HCSG | Healthcare Services Group, Inc. | 1.64B | -2.05% | 747,651 | 1.85B |
| 311 | TDOC | Teladoc Health, Inc. | 1.64B | -4.73% | 3,432,580 | 2.51B |
| 312 | SVRA | Savara Inc. | 1.62B | 2.74% | 2,065,100 | - |
| 313 | FTRE | Fortrea Holdings Inc. | 1.61B | -2.63% | 847,444 | 2.71B |
| 314 | AAPG | Ascentage Pharma Group International | 1.60B | 0.96% | 7,628 | 82.08M |
| 315 | AKTS | Aktis Oncology, Inc. | 1.59B | 4.02% | 711,794 | 8.28M |
| 316 | COAG | Hemab Therapeutics Holdings, Inc. | 1.58B | 7.62% | 347,152 | - |
| 317 | MLTX | MoonLake Immunotherapeutics | 1.58B | -0.42% | 1,195,226 | - |
| 318 | KMTS | Kestra Medical Technologies, Ltd. | 1.56B | -3.77% | 694,829 | 83.72M |
| 319 | INNV | InnovAge Holding Corp. | 1.56B | -1.12% | 296,621 | 949.17M |
| 320 | AVBP | ArriVent BioPharma, Inc. | 1.56B | -2.28% | 857,915 | - |
| 321 | NVAX | Novavax, Inc. | 1.54B | -1.16% | 3,793,611 | 596.34M |
| 322 | XERS | Xeris Biopharma Holdings, Inc. | 1.50B | -3.02% | 3,676,872 | 314.85M |
| 323 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.49B | -2.70% | 2,248,487 | 204.73M |
| 324 | PSNL | Personalis, Inc. | 1.48B | 0.93% | 4,427,166 | 64.52M |
| 325 | PRGO | Perrigo Company plc | 1.46B | -5.99% | 2,865,144 | 4.18B |
| 326 | ARDT | Ardent Health, Inc. | 1.46B | -6.19% | 625,013 | 6.43B |
| 327 | INBX | Inhibrx Biosciences, Inc. | 1.42B | -3.62% | 499,748 | 1.30M |
| 328 | CDNA | CareDx, Inc. | 1.42B | -2.68% | 1,642,167 | 412.82M |
| 329 | INSP | Inspire Medical Systems, Inc. | 1.42B | -1.56% | 1,254,042 | 915.25M |
| 330 | ATEC | Alphatec Holdings, Inc. | 1.42B | -1.81% | 3,318,993 | 787.08M |
| 331 | STAA | STAAR Surgical Company | 1.40B | 6.03% | 1,503,016 | 290.38M |
| 332 | AHG | Akso Health Group | 1.37B | 2.56% | 5,772 | 14.84M |
| 333 | OMDA | Omada Health, Inc. | 1.37B | -0.09% | 1,252,153 | 283.30M |
| 334 | IMTX | Immatics N.V. | 1.36B | -2.73% | 448,758 | 43.00M |
| 335 | PNTG | The Pennant Group, Inc. | 1.36B | -1.26% | 279,821 | 1.02B |
| 336 | ENOV | Enovis Corporation | 1.36B | -7.41% | 1,213,833 | 2.28B |
| 337 | CRVS | Corvus Pharmaceuticals, Inc. | 1.35B | 2.88% | 2,615,067 | - |
| 338 | IART | Integra LifeSciences Holdings Corporation | 1.35B | -0.92% | 702,387 | 1.64B |
| 339 | ARDX | Ardelyx, Inc. | 1.34B | 0.93% | 3,565,476 | 427.68M |
| 340 | JBIO | Jade Biosciences, Inc. | 1.34B | 0.36% | 878,517 | - |
| 341 | AHCO | AdaptHealth Corp. | 1.33B | -1.58% | 1,315,887 | 3.29B |
| 342 | BLFS | BioLife Solutions, Inc. | 1.33B | -2.65% | 465,030 | 101.66M |
| 343 | PAHC | Phibro Animal Health Corporation | 1.32B | -2.05% | 291,590 | 1.50B |
| 344 | MNKD | MannKind Corporation | 1.31B | 0.71% | 6,892,668 | 360.78M |
| 345 | MGTX | MeiraGTx Holdings plc | 1.31B | -3.55% | 804,844 | 79.76M |
| 346 | CAPR | Capricor Therapeutics, Inc. | 1.29B | 0.14% | 1,456,708 | 11.13M |
| 347 | AVLN | Avalyn Pharma Inc. | 1.28B | 1.83% | 419,969 | - |
| 348 | AMN | AMN Healthcare Services, Inc. | 1.24B | -3.52% | 1,466,141 | 3.42B |
| 349 | NUTX | Nutex Health Inc. | 1.24B | -4.44% | 154,710 | 879.95M |
| 350 | IRMD | IRADIMED CORPORATION | 1.23B | -3.92% | 275,941 | 86.28M |
| 351 | XNCR | Xencor, Inc. | 1.22B | 5.04% | 1,164,152 | 97.36M |
| 352 | ALVO | Alvotech | 1.21B | -2.58% | 385,125 | 562.04M |
| 353 | SDGR | Schrödinger, Inc. | 1.20B | -2.43% | 1,033,213 | 254.91M |
| 354 | WVE | Wave Life Sciences Ltd. | 1.20B | -2.19% | 2,771,937 | 71.80M |
| 355 | SANA | Sana Biotechnology, Inc. | 1.19B | -3.40% | 3,375,677 | - |
| 356 | QDEL | QuidelOrtho Corporation | 1.18B | 1.47% | 1,756,442 | 2.66B |
| 357 | EYPT | EyePoint, Inc. | 1.17B | -0.07% | 1,899,461 | 7.61M |
| 358 | LMRI | Lumexa Imaging Holdings, Inc. | 1.17B | -1.06% | 394,997 | 1.03B |
| 359 | AVNS | Avanos Medical, Inc. | 1.17B | - | 1,000,597 | 715.90M |
| 360 | COLL | Collegium Pharmaceutical, Inc. | 1.16B | -1.67% | 445,359 | 796.33M |
| 361 | DRTS | Alpha Tau Medical Ltd. | 1.15B | 0.20% | 548,450 | - |
| 362 | AORT | Artivion, Inc. | 1.14B | -3.60% | 665,781 | 458.69M |
| 363 | SPTX | Seaport Therapeutics, Inc. | 1.14B | 16.62% | 223,408 | - |
| 364 | CGEM | Cullinan Therapeutics, Inc. | 1.13B | 1.49% | 618,635 | - |
| 365 | AZTA | Azenta, Inc. | 1.13B | -3.39% | 556,520 | 596.48M |
| 366 | ORIC | ORIC Pharmaceuticals, Inc. | 1.13B | 0.18% | 2,183,595 | - |
| 367 | PRCT | PROCEPT BioRobotics Corporation | 1.13B | -5.87% | 2,024,246 | 322.02M |
| 368 | VOR | Vor Biopharma Inc. | 1.10B | 1.04% | 2,135,587 | - |
| 369 | SLDB | Solid Biosciences Inc. | 1.08B | -1.35% | 1,378,338 | - |
| 370 | KURA | Kura Oncology, Inc. | 1.08B | 1.08% | 1,918,783 | 71.64M |
| 371 | OLMA | Olema Pharmaceuticals, Inc. | 1.07B | -2.85% | 1,521,797 | - |
| 372 | USPH | U.S. Physical Therapy, Inc. | 1.07B | -2.12% | 158,907 | 787.69M |
| 373 | OPK | OPKO Health, Inc. | 1.06B | -5.37% | 2,062,861 | 581.12M |
| 374 | BIOA | BioAge Labs, Inc. | 1.05B | -3.16% | 653,491 | 10.32M |
| 375 | TNDM | Tandem Diabetes Care, Inc. | 1.04B | -1.75% | 1,871,095 | 1.03B |
| 376 | ABUS | Arbutus Biopharma Corporation | 1.03B | 0.77% | 3,068,879 | 191.45M |
| 377 | CRON | Cronos Group Inc. | 1.03B | - | 604,268 | 159.54M |
| 378 | CERT | Certara, Inc. | 1.02B | -8.79% | 4,616,206 | 419.75M |
| 379 | JANX | Janux Therapeutics, Inc. | 1.02B | 3.16% | 1,365,418 | 13.73M |
| 380 | IVA | Inventiva S.A. | 1.01B | -3.73% | 3,403,329 | 7.94M |
| 381 | PHAR | Pharming Group N.V. | 1.01B | -1.11% | 8,043 | 369.49M |
| 382 | BVS | Bioventus Inc. | 1.01B | 5.40% | 861,524 | 576.30M |
| 383 | CNMD | CONMED Corporation | 1.01B | -1.90% | 533,491 | 1.37B |
| 384 | AVTX | Avalo Therapeutics, Inc. | 1.01B | -0.21% | 1,296,636 | 59.00K |
| 385 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.01B | -4.22% | 4,050,819 | 69.64M |
| 386 | PCRX | Pacira BioSciences, Inc. | 1.00B | -1.16% | 330,880 | 734.86M |
| 387 | GDRX | GoodRx Holdings, Inc. | 1.00B | -2.31% | 600,814 | 787.89M |
| 388 | GERN | Geron Corporation | 1.00B | 4.70% | 13,532,896 | 196.12M |
| 389 | EVO | Evotec SE | 991.39M | -2.46% | 18,330 | 859.03M |
| 390 | ETON | Eton Pharmaceuticals, Inc. | 990.78M | -4.16% | 400,837 | 86.93M |
| 391 | LBRX | LB Pharmaceuticals Inc | 979.88M | -0.35% | 305,712 | - |
| 392 | GLAS | Glass House Brands Inc. | 977.51M | -0.61% | 359,570 | 177.68M |
| 393 | ANNX | Annexon, Inc. | 976.50M | -7.31% | 7,548,993 | - |
| 394 | DBVT | DBV Technologies S.A. | 971.65M | -3.46% | 137,322 | 5.74M |
| 395 | PHAT | Phathom Pharmaceuticals, Inc. | 957.93M | 4.42% | 1,384,167 | 204.89M |
| 396 | DSGN | Design Therapeutics, Inc. | 954.34M | 3.87% | 1,036,386 | - |
| 397 | AVR | Anteris Technologies Global Corp. | 945.19M | -2.12% | 1,503,454 | 1.85M |
| 398 | REPL | Replimune Group, Inc. | 933.47M | -3.39% | 3,269,454 | - |
| 399 | INMD | InMode Ltd. | 916.17M | -0.55% | 450,401 | 374.64M |
| 400 | ANRO | Alto Neuroscience, Inc. | 915.60M | 1.52% | 884,717 | - |
| 401 | TENX | Tenax Therapeutics, Inc. | 905.86M | 2.01% | 1,207,206 | - |
| 402 | TBPH | Theravance Biopharma, Inc. | 881.08M | -0.06% | 448,130 | 109.78M |
| 403 | TALK | Talkspace, Inc. | 874.42M | 0.19% | 2,453,668 | 238.37M |
| 404 | ZVRA | Zevra Therapeutics, Inc. | 871.95M | 2.15% | 2,878,017 | 122.29M |
| 405 | GMRS | GMR Solutions Inc. | 841.50M | 5.70% | 668,358 | 5.83B |
| 406 | PRME | Prime Medicine, Inc. | 834.45M | 15.79% | 11,421,894 | 4.03M |
| 407 | CTMX | CytomX Therapeutics, Inc. | 833.80M | -0.26% | 3,166,367 | 35.54M |
| 408 | AMPH | Amphastar Pharmaceuticals, Inc. | 832.47M | -5.98% | 438,665 | 720.53M |
| 409 | OCS | Oculis Holding AG | 827.32M | 1.03% | 521,377 | 1.40M |
| 410 | HSTM | HealthStream, Inc. | 823.28M | -0.95% | 180,791 | 311.78M |
| 411 | ESPR | Esperion Therapeutics, Inc. | 822.04M | 0.95% | 51,748,330 | 418.24M |
| 412 | SPRY | ARS Pharmaceuticals, Inc. | 804.36M | -1.10% | 2,036,599 | 98.99M |
| 413 | AURA | Aura Biosciences, Inc. | 799.67M | 3.13% | 1,210,986 | - |
| 414 | RIGL | Rigel Pharmaceuticals, Inc. | 794.29M | 0.87% | 313,678 | 299.77M |
| 415 | RGNX | REGENXBIO Inc. | 787.37M | 1.40% | 2,388,233 | 87.82M |
| 416 | IRWD | Ironwood Pharmaceuticals, Inc. | 785.21M | 6.71% | 4,987,325 | 361.51M |
| 417 | IMMX | Immix Biopharma, Inc. | 783.09M | -8.49% | 2,430,411 | - |
| 418 | CLYM | Climb Bio, Inc. | 777.03M | 1.12% | 1,401,842 | - |
| 419 | ACRS | Aclaris Therapeutics, Inc. | 769.55M | -1.96% | 1,214,045 | 8.37M |
| 420 | NGNE | Neurogene Inc. | 762.00M | 3.91% | 533,190 | 925.00K |
| 421 | SIBN | SI-BONE, Inc. | 749.06M | -2.37% | 1,292,238 | 206.22M |
| 422 | ODTX | Odyssey Therapeutics, Inc. | 744.98M | -2.20% | 305,364 | 1.06M |
| 423 | OMER | Omeros Corporation | 741.12M | -0.87% | 1,496,610 | 9.89M |
| 424 | CBLL | CeriBell, Inc. | 736.09M | -2.27% | 255,547 | 95.07M |
| 425 | ALLO | Allogene Therapeutics, Inc. | 731.73M | -1.40% | 12,427,645 | 22.00K |
| 426 | TRAX | First Tracks Biotherapeutics, Inc. | 724.71M | 5.01% | 552,011 | - |
| 427 | CADL | Candel Therapeutics, Inc. | 723.91M | 0.30% | 1,945,023 | - |
| 428 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 722.57M | 8.81% | 723,652 | - |
| 429 | FTH | Faeth Therapeutics, Inc. | 722.32M | 7.32% | 100,286 | - |
| 430 | BBNX | Beta Bionics, Inc. | 721.01M | -4.82% | 999,485 | 110.24M |
| 431 | SSII | SS Innovations International, Inc. | 720.47M | 0.56% | 85,916 | 48.47M |
| 432 | CSTL | Castle Biosciences, Inc. | 717.00M | -0.80% | 413,163 | 339.92M |
| 433 | SLBT | SL Science Holding Limited | 701.45M | -2.69% | 72,903 | - |
| 434 | CRMD | CorMedix Inc. | 692.73M | -0.45% | 824,494 | 400.05M |
| 435 | SGP | SpyGlass Pharma, Inc. | 684.05M | 4.82% | 140,853 | - |
| 436 | FDMT | 4D Molecular Therapeutics, Inc. | 680.64M | 1.56% | 757,161 | 88.24M |
| 437 | TCMD | Tactile Systems Technology, Inc. | 676.24M | -4.80% | 199,846 | 343.52M |
| 438 | RLMD | Relmada Therapeutics, Inc. | 672.35M | - | 1,971,904 | - |
| 439 | TECX | Tectonic Therapeutic, Inc. | 669.48M | -2.90% | 279,743 | - |
| 440 | MNPR | Monopar Therapeutics Inc. | 664.99M | 4.25% | 298,066 | - |
| 441 | DRUG | Bright Minds Biosciences Inc. | 663.93M | 8.11% | 254,177 | - |
| 442 | PHR | Phreesia, Inc. | 658.91M | -2.65% | 760,376 | 495.59M |
| 443 | ACHV | Achieve Life Sciences, Inc. | 637.51M | -4.75% | 2,430,574 | - |
| 444 | MDXG | MiMedx Group, Inc. | 634.51M | 1.43% | 1,307,763 | 389.42M |
| 445 | EVH | Evolent Health, Inc. | 629.89M | 2.19% | 1,490,879 | 1.89B |
| 446 | CERS | Cerus Corporation | 629.16M | -2.48% | 2,120,377 | 216.56M |
| 447 | AGMB | AgomAb Therapeutics NV | 627.42M | -4.07% | 45,574 | - |
| 448 | GYRE | Gyre Therapeutics, Inc. | 626.81M | -2.14% | 112,659 | 117.05M |
| 449 | ALT | Altimmune, Inc. | 604.81M | 2.98% | 3,520,265 | 36.00K |
| 450 | BWAY | BrainsWay Ltd. | 604.29M | -0.13% | 75,714 | 56.22M |
| 451 | KYTX | Kyverna Therapeutics, Inc. | 602.48M | 2.38% | 1,195,545 | - |
| 452 | DNA | Ginkgo Bioworks Holdings, Inc. | 592.49M | -2.89% | 1,098,030 | 151.40M |
| 453 | NVCT | Nuvectis Pharma, Inc. | 591.10M | -2.34% | 285,625 | - |
| 454 | FLGT | Fulgent Genetics, Inc. | 585.34M | -1.95% | 264,832 | 320.35M |
| 455 | CTNM | Contineum Therapeutics, Inc. | 585.10M | 7.49% | 596,006 | - |
| 456 | EIKN | Eikon Therapeutics, Inc. | 580.37M | -7.59% | 541,835 | - |
| 457 | NPCE | NeuroPace, Inc. | 572.09M | -5.73% | 109,123 | 99.53M |
| 458 | ASMB | Assembly Biosciences, Inc. | 569.35M | -0.81% | 135,958 | 71.10M |
| 459 | CTKB | Cytek Biosciences, Inc. | 566.94M | -3.73% | 1,174,833 | 204.17M |
| 460 | TOI | The Oncology Institute, Inc. | 564.90M | -2.59% | 2,177,826 | 545.76M |
| 461 | XOMA | XOMA Royalty Corporation | 564.35M | 2.53% | 255,336 | 48.56M |
| 462 | EDIT | Editas Medicine, Inc. | 563.20M | -2.13% | 2,454,890 | 38.69M |
| 463 | CBIO | Crescent Biopharma, Inc. | 558.58M | -1.29% | 177,156 | 11.88M |
| 464 | PROK | ProKidney Corp. | 555.79M | -5.64% | 1,024,209 | 889.00K |
| 465 | MYGN | Myriad Genetics, Inc. | 554.41M | 0.17% | 1,430,202 | 829.00M |
| 466 | ARVN | Arvinas, Inc. | 552.30M | -0.35% | 631,111 | 89.40M |
| 467 | CTEV | Claritev Corporation | 545.87M | 1.27% | 79,479 | 978.76M |
| 468 | AQST | Aquestive Therapeutics, Inc. | 540.69M | -0.46% | 1,217,296 | 50.27M |
| 469 | WEAV | Weave Communications, Inc. | 537.07M | -0.88% | 1,129,664 | 248.72M |
| 470 | ANGO | AngioDynamics, Inc. | 533.95M | -1.99% | 287,259 | 313.73M |
| 471 | STRO | Sutro Biopharma, Inc. | 527.60M | -0.90% | 424,161 | 99.61M |
| 472 | STTK | Shattuck Labs, Inc. | 527.56M | -5.23% | 1,033,575 | 1.00M |
| 473 | ZURA | Zura Bio Limited | 521.54M | 8.07% | 1,188,105 | - |
| 474 | TLRY | Tilray Brands, Inc. | 521.27M | 1.39% | 4,010,120 | 858.28M |
| 475 | CLPT | ClearPoint Neuro, Inc. | 518.52M | -1.09% | 421,711 | 40.61M |
| 476 | RZLT | Rezolute, Inc. | 518.16M | -0.20% | 1,831,480 | - |
| 477 | PRTA | Prothena Corporation plc | 515.68M | 1.76% | 444,246 | 57.94M |
| 478 | CABA | Cabaletta Bio, Inc. | 510.36M | 0.97% | 7,877,201 | - |
| 479 | OVID | Ovid Therapeutics Inc. | 509.53M | -1.09% | 3,027,380 | 7.12M |
| 480 | PRLD | Prelude Therapeutics Incorporated | 507.79M | 3.02% | 282,567 | 16.72M |
| 481 | OCGN | Ocugen, Inc. | 507.78M | - | 7,570,739 | 4.47M |
| 482 | KIDS | OrthoPediatrics Corp. | 507.54M | -0.30% | 149,955 | 243.30M |
| 483 | NNNN | Anbio Biotechnology | 504.31M | -1.79% | 37,303 | 8.65M |
| 484 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 5.42M |
| 485 | FBRX | Forte Biosciences, Inc. | 502.89M | -7.51% | 590,079 | - |
| 486 | VALN | Valneva SE | 493.63M | 0.95% | 12,850 | 180.25M |
| 487 | NRC | NRC Health | 492.88M | -3.95% | 73,248 | 138.64M |
| 488 | CYH | Community Health Systems, Inc. | 483.57M | -6.54% | 2,043,813 | 12.29B |
| 489 | EVMN | Evommune, Inc. | 477.24M | -0.67% | 1,142,286 | 10.00M |
| 490 | SLN | Silence Therapeutics plc | 469.98M | -1.97% | 494,240 | 839.00K |
| 491 | OFIX | Orthofix Medical Inc. | 466.47M | -1.54% | 345,937 | 825.37M |
| 492 | PACB | Pacific Biosciences of California, Inc. | 465.90M | -3.85% | 4,142,714 | 160.03M |
| 493 | VMD | Viemed Healthcare, Inc. | 465.41M | 0.58% | 294,187 | 286.57M |
| 494 | CCCC | C4 Therapeutics, Inc. | 463.28M | -3.68% | 6,712,598 | 34.86M |
| 495 | BNTC | Benitec Biopharma Inc. | 463.10M | 0.30% | 79,042 | - |
| 496 | RCKT | Rocket Pharmaceuticals, Inc. | 462.98M | 4.18% | 4,053,211 | - |
| 497 | SOPH | SOPHiA GENETICS SA | 462.26M | 1.29% | 311,930 | 81.18M |
| 498 | SGMT | Sagimet Biosciences Inc. | 459.43M | -3.25% | 1,278,920 | - |
| 499 | MOBI | Mobia Medical, Inc. | 455.84M | 11.01% | 177,673 | 38.45M |
| 500 | VREX | Varex Imaging Corporation | 453.50M | 1.03% | 421,874 | 857.50M |